Pfizer issues global market withdrawal of sickle cell disease therapy Oxbryta aliu Wed, 09/25/2024 – 17:49 More: Pfizer issues global market withdrawal of sickle cell disease therapy Oxbryta Source: fierce
read morePrivate equity firms bid on Sanofi’s $16B+ consumer health business: Bloomberg fkansteiner Wed, 09/25/2024 – 11:40 More: Private equity firms bid on Sanofi's B+ consumer health business: Bloomberg Source: fierce
read moreWith success in myasthenia gravis trial, Amgen’s Uplizna looks set up to add new indication kdunleavy Wed, 09/25/2024 – 11:05 More: With success in myasthenia gravis trial, Amgen's Uplizna looks set up to add new indication Source: fierce
read moreEmergent BioSolutions racks up $400M in mpox preparedness orders as outbreak continues its spread zbecker Wed, 09/25/2024 – 10:51 More: Emergent BioSolutions racks up 0M in mpox preparedness orders as outbreak continues its spread Source: fierce
read moreCiting enrollment challenges, Bristol Myers and 2seventy scrap Abecma trial in first-line myeloma aliu Wed, 09/25/2024 – 10:23 More: Citing enrollment challenges, Bristol Myers and 2seventy scrap Abecma trial in first-line myeloma Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals